Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 54
Filter
1.
Transplant Proc ; 50(9): 2885-2888, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30401417

ABSTRACT

Isolated biliary leakage is difficult to manage, and afflicted patients often develop refractory fistula. The present case was a 43-year-old male donor whose wife developed acute fulminant liver failure. Computed tomography (CT) volumetry showed that the estimated remnant liver volume was only 394 mL (31%) if his right lobe would be harvested. Since remnant liver volume was marginal, our proposed cut line for the right hepatectomy was set in order to preserve branches of the middle hepatic vein draining segments 4b+8 and 5. Right hepatectomy was performed, but on postoperative day 14, the donor developed fever and right back pain, and enhanced CT showed a 6 cm intra-abdominal abscess at the site of cutting, and we diagnosed it as an isolated biliary fistula since the isolated segment 5/8 was receiving arterial blood supply and exhibiting regrowth. A transabdominal abscess drainage was performed, after which the patient lost 30 to 50 mL of bile juice per day in drainage until 2 months after the drainage procedure. Ethanol injection, acetic acid injection, and transarterial or portal embolization for the isolated liver were proposed, but these all were impossible to carry out because there were no accessible routes. Thus, re-abscess drainage with a 7-French drainage catheter was performed through the isolated liver on postoperative day 53, and the isolated functional liver was punctured to induce liver atrophy. After this drainage, the isolated liver started to shrink and bile output had been stopped. In conclusion, our punctured-liver drainage could be effective for the treatment of isolated biliary fistula, allowing physicians to avoid an invasive additional liver resection or other invasive percutaneous approach using chemical reagents.


Subject(s)
Biliary Fistula/etiology , Biliary Fistula/surgery , Drainage/methods , Hepatectomy/adverse effects , Tissue and Organ Harvesting/adverse effects , Adult , Humans , Male , Tissue Donors
2.
Diagn Interv Imaging ; 98(1): 43-50, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27316574

ABSTRACT

PURPOSE: To evaluate the clinical utility of percutaneous drainage of pancreatic fistula following pancreatectomy with real-time CT-fluoroscopic guidance. MATERIAL AND METHODS: During January 2007 through March 2013, of 295 patients who underwent pancreatectomy, 20 patients received percutaneous drainage of pancreatic fistula with real-time CT-fluoroscopic guidance. The mean diameter of pancreatic fluid collections was 8.1±2.7 (SD)cm (range: 3.5-15.0cm). Feasibility, safety, and clinical success were evaluated. Primary and secondary clinical successes were defined respectively as the resolution of pancreatic fistula by initial drainage alone, and after additional intervention. Factors affecting primary clinical success and the drainage period were also evaluated. RESULTS: Drainage catheters were placed in planned sites in all patients. No major complication occurred except in 1/20 patient (5%) who experienced endotoxin shock. Primary and secondary clinical success rates were, respectively, 50% (10/20) and 90% (18/20). An amylase level greater than 30,000IU/L in the fluid collection was a significant factor lowering the primary clinical success rate (P<0.02) and prolonging the drainage period (>30 days) (P<0.02). CONCLUSION: Real-time CT-fluoroscopic guided drainage is a feasible, safe, and useful therapeutic option for the management of pancreatic fistula after pancreatectomy. The fluid amylase level is a useful indicator to predict refractory pancreatic fistula.


Subject(s)
Drainage/methods , Fluoroscopy , Pancreatectomy/adverse effects , Pancreatic Fistula/therapy , Radiography, Interventional , Tomography, X-Ray Computed , Aged , Aged, 80 and over , Amylases/analysis , Catheters , Female , Humans , Male , Middle Aged , Pancreatic Fistula/etiology , Retrospective Studies
3.
Transplant Proc ; 48(4): 1142-8, 2016 May.
Article in English | MEDLINE | ID: mdl-27320575

ABSTRACT

OBJECTIVES: Hepatic artery thrombosis (HAT) is a serious complication after living-donor liver transplantation (LDLT) leading to patient death in the absence of revascularization. With the recent advances in interventional radiology, interventional endovascular techniques have been used as alternative therapeutic options for HAT. This study evaluates the feasibility and clinical outcomes of endovascular treatment for HAT after LDLT. METHODS: The medical records of 120 patients who underwent adult-to-adult LDLT between February 2002 and February 2015 in our hospital were retrospectively reviewed to evaluate the frequency of HAT and outcomes of endovascular treatment. RESULTS: A total of nine patients (7.5%) developed HAT after LDLT, and the all patients underwent endovascular treatment. Overall technical success with endovascular treatment was achieved in 77.8% (7 of 9) of the patients. Intra-arterial thrombolysis was successful in one patient. Further intervention after intra-arterial thrombolysis was performed in the form of percutaneous transluminal angioplasty in six patients, and percutaneous transluminal angioplasty with stenting in two patients. Two patients with failure of revascularization by endovascular treatment were treated conservatively and developed hepatic arterial collaterals, and the both patients could avoid the graft failure. The overall survival rates did not differ significantly between the patients without HAT (n = 111) and those with HAT (n = 9) (1-, 3-, and 5-year overall survival rates of the patients without HAT vs. with HAT: 78.1%, 67.8%, and 65.3% vs. 66.7%, 66.7%, and 66.7%, respectively; P = .77). CONCLUSION: Interventional endovascular treatment of HAT in LDLT is a feasible and reliable procedure in avoiding early graft failure with acceptable long-term patient outcome.


Subject(s)
Angioplasty/methods , Endovascular Procedures/methods , Hepatic Artery/surgery , Liver Diseases/surgery , Liver Transplantation , Postoperative Complications/surgery , Thrombolytic Therapy/methods , Thrombosis/surgery , Adult , Aged , Feasibility Studies , Female , Humans , Living Donors , Male , Middle Aged , Retrospective Studies , Stents , Treatment Outcome , Young Adult
4.
Clin Radiol ; 68(2): 162-6, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22906574

ABSTRACT

AIM: To verify the usefulness of a sliding scale of imaging parameters to reduce radiation exposure during chest interventional radiology (IR), and to identify factors that increase radiation exposure in order to obtain acceptable computed tomography (CT)-fluoroscopy image quality. MATERIALS AND METHODS: The institutional review board approved this retrospective study, for which the need for informed consent was waived. Interventional radiologists determined the optimal CT-fluoroscopy imaging parameters using the sliding scale based on the radiation exposure dose. The imaging parameters were changed from those generating low radiation (120 kV/10 mA, 1.2 mGy/s) to others generating higher radiation exposure until acceptable image quality was obtained for each procedure. Validation of the imaging parameter sliding scale was done using regression analysis. Factors that increase radiation exposure were identified using multiple regression analysis. RESULTS: In 125 patients, 217 procedures were performed, of which 72 procedures (33.2%, 72/217) were performed with imaging parameters of minimum radiation exposure, but increased radiation exposure was necessary in 145 (66.8%, 145/217). Significant correlation was found between the radiation exposure dose and the percentage achievement of acceptable image quality (R(2) = 0.98). Multivariate regression analysis showed that high body weight (p < 0.0001), long device passage (p < 0.0001), and lesions above the aortic arch (p = 0.04) were significant independent factors increasing radiation exposure. CONCLUSION: Although increased radiation exposure dose might be necessary to obtain acceptable chest CT-fluoroscopy images depending on the patient, lesion, and procedure characteristics, a sliding scale of imaging parameters helps to reduce radiation exposure.


Subject(s)
Fluoroscopy/methods , Lung Neoplasms/diagnostic imaging , Radiation Dosage , Radiography, Interventional/methods , Tomography, X-Ray Computed/methods , Adult , Aged , Aged, 80 and over , Cohort Studies , Female , Humans , Lung Neoplasms/pathology , Male , Middle Aged , Multivariate Analysis , Patient Safety , Radiation Protection/methods , Radiography, Thoracic/methods , Regression Analysis , Retrospective Studies , Risk Factors , Young Adult
5.
Br J Radiol ; 82(983): e225-7, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19890115

ABSTRACT

A 58-year-old man with primary lung cancer underwent lung radiofrequency (RF) ablation. Pneumothorax developed 12 days after lung RF ablation. Despite chest drainage for 1 month, air leakage continued through a bronchopleural fistula. Bronchial occlusion was performed with a silicone embolus, causing cessation of the air leakage.


Subject(s)
Bronchial Fistula/therapy , Catheter Ablation/adverse effects , Embolization, Therapeutic , Fistula/therapy , Pleural Diseases/therapy , Adenocarcinoma/therapy , Bronchial Fistula/etiology , Bronchoscopy/adverse effects , Fistula/etiology , Humans , Lung Neoplasms/therapy , Male , Middle Aged , Pleural Diseases/etiology , Pneumothorax/etiology , Pneumothorax/therapy , Radiography, Interventional , Silicones/therapeutic use
6.
Br J Radiol ; 81(964): e100-2, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18344264

ABSTRACT

A 75-year-old woman underwent radiofrequency (RF) ablation for the treatment of two painful disseminated tumours that appeared and rapidly became larger at the anterior abdominal wound 16 months after she had undergone surgery for gastric cancer. RF ablation was performed under CT-fluoroscopic guidance for both tumours, which measured 5 cm and 3 cm in maximum diameter. Pain was relieved immediately after RF ablation, and both tumours showed significant involution upon physical examination and CT studies. The patient is still alive 15 months after RF ablation, with no evidence of tumour recurrence.


Subject(s)
Abdominal Neoplasms/surgery , Abdominal Wall/surgery , Catheter Ablation , Neoplasm Seeding , Stomach Neoplasms/surgery , Abdominal Neoplasms/diagnostic imaging , Abdominal Neoplasms/secondary , Aged , Female , Fluoroscopy , Gastrectomy/adverse effects , Humans , Pain/etiology , Pain/surgery , Recurrence , Stomach Neoplasms/pathology , Tomography, X-Ray Computed , Treatment Outcome
7.
Plant Cell Rep ; 27(5): 931-8, 2008 May.
Article in English | MEDLINE | ID: mdl-18301901

ABSTRACT

Persimmon (Diospyros kaki Thunb.) is an important fruit in Asian countries, where it is eaten as a fresh fruit and is also used for many other purposes. To understand the molecular mechanism of fruit development and ripening in persimmon, we generated a total of 9,952 expressed sequence tags (ESTs) from randomly selected clones of two different cDNA libraries. One cDNA library was derived from fruit of "Saijo" persimmon at an early stage of development, and the other from ripening fruit. These ESTs were clustered into 6,700 non-redundant sequences. Of the 6,700 non-redundant sequences evaluated, the deduced amino acid sequences of 4,356 (65%) showed significant homology to known proteins, and 2,344 (35%) showed no significant similarity to any known proteins in Arabidopsis databases. We report comparison of genes identified in the two cDNA libraries and describe some putative genes involved in proanthocyanidin and carotenoid synthesis. This study provides the first global overview of a set of genes that are expressed during fruit development and ripening in persimmon.


Subject(s)
Diospyros/genetics , Expressed Sequence Tags , Gene Expression Regulation, Developmental , Gene Expression Regulation, Plant , Diospyros/growth & development , Fruit/genetics , Fruit/growth & development , Gene Library , Models, Biological , Polymerase Chain Reaction , Sequence Analysis, DNA
8.
Br J Radiol ; 81(963): 244-9, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18208852

ABSTRACT

This retrospective study was conducted to review the complications of lung radiofrequency (RF) ablation and to clarify the effects of inflammation after lung RF ablation on mortality and morbidity. Complications were evaluated by reviewing medical records on an RF session basis. The C-reactive protein (CRP) value was used as an indicator of inflammation and was measured before and every 1-2 days during the hospital stay after RF ablation. The relationships between CRP values and patient baselines were evaluated to identify factors affecting lung inflammation. 130 patients who underwent 327 lung RF ablation sessions were enrolled in this study. The major complication rate was 18.3% (60/327). Inflammation-related complications such as interstitial pneumonia (n = 2) and aseptic pleuritis (n = 2) developed in four sessions (1.2%). Death occurred in two patients with interstitial pneumonia (0.6%). The mean CRP value increased significantly from 1.3+/-2.6 mg dl(-1) to 3.4+/-5.6 mg dl(-1) (p<0.01) after RF ablation. Large tumour size (>or=2 cm) and previous external-beam radiotherapy were significant factors associated with an increased CRP value in both univariate and multivariate analyses. In conclusion, although the incidence rate is low, fatal lung inflammation may develop after lung RF ablation. Large tumour size and previous external-beam radiotherapy are risk factors for severe lung inflammation.


Subject(s)
Catheter Ablation/adverse effects , Lung Neoplasms/surgery , Pneumonia/mortality , Adolescent , Adult , Aged , Aged, 80 and over , C-Reactive Protein/analysis , Child , Female , Humans , Lung Neoplasms/pathology , Male , Middle Aged , Pneumonia/etiology , Retrospective Studies , Risk Factors , Survival Rate , Tomography, X-Ray Computed
9.
Aliment Pharmacol Ther ; 27(12): 1253-60, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18221404

ABSTRACT

BACKGROUND: Radiofrequency ablation (RFA) therapy for hepatocellular carcinoma has enabled good local control to be possible. However, after successful local control, distant recurrences frequently occur in the remnant liver. AIM: To identify the predictive factors for distant recurrence after RFA. METHODS: A total of 117 patients with initial non-advanced hepatocellular carcinoma with HCV who underwent RFA in our hospital were selected for this study. After transcatheter chemoembolization, RFA was performed under real-time computed tomography-fluoroscopic guidance. We studied survival rates, local (adjacent to treated tumour) and distant (intrahepatic site distant from the treated tumours) recurrence rates, as well as predictive factors for distant recurrence. RESULTS: After RFA, survival rates were 98.2% and 64.7% at 1 and 5 years, respectively. Child B patients had a significantly worse survival than Child A. Recurrence rates were 2.4% at 5 years for local, and 17.1% and 76.9% at 1 and 5 years, respectively, for distant. The Kaplan-Meier method revealed significantly high recurrence rates in cases with low albumin levels (Alb < 3.5 g/dL), high aspartate aminotransferase levels (AST > 60 IU/L), high alanine aminotransferase levels (ALT > 60 IU/L), low platelet counts (Plt < 10 x 10(4)/microL), and high alpha-fetoprotein levels (AFP > 50 ng/mL). On multivariate analysis, low Alb levels and high AST levels were independent predictive factors for distant recurrence. CONCLUSIONS: Although RFA enables good local control for initial hepatocellular carcinoma, distant recurrence is observed at high rates in HCV patients. Low albumin and high AST levels are predictive factors for distant recurrence.


Subject(s)
Carcinoma, Hepatocellular/therapy , Catheter Ablation/methods , Chemoembolization, Therapeutic/methods , Liver Neoplasms/therapy , Neoplasm Recurrence, Local/prevention & control , Adult , Aged , Aged, 80 and over , Combined Modality Therapy , Female , Fluoroscopy , Humans , Male , Middle Aged , Predictive Value of Tests , Prognosis
10.
Int J Oral Maxillofac Surg ; 35(1): 49-54, 2006 Jan.
Article in English | MEDLINE | ID: mdl-15961278

ABSTRACT

The purpose of this retrospective study is to assess the relationship between an initial and persisting condition of disk displacement (DD) and the long-term course of radiographically evident degenerative changes of the temporomandibular joint (TMJ). Nineteen patients agreed to a radiographic follow-up examination of 29 joints and were included in this study. The joints were radiographically assessed at the first visit and at least 46 months after the first visit (mean 89.3 months). At the time of the follow-up, all subjects had a good clinical course after a favorable response to the treatments. There were significant relationships between the initial diagnosis of DD and the interval change in the morphology of the articular eminence. The articular eminence became flattened or deformed only in the joints with persistent DD without reduction. And there was a tendency that the condyle became smaller in the joints initially with permanent DD and in the joints which show a progression in the disk-condylar relationship. The results of this study suggested that, in the joints with persisting non-reducing disk displacement, flattening and deformation of the articular eminence and regression of the condylar size were likely to happen even after symptoms and signs of TMJ disorders were resolved or reduced.


Subject(s)
Joint Dislocations/diagnostic imaging , Osteoarthritis/diagnostic imaging , Temporomandibular Joint Disc/diagnostic imaging , Temporomandibular Joint Disorders/diagnostic imaging , Adolescent , Adult , Bone Resorption/diagnostic imaging , Disease Progression , Female , Follow-Up Studies , Humans , Joint Dislocations/therapy , Longitudinal Studies , Magnetic Resonance Imaging , Male , Mandibular Condyle/diagnostic imaging , Middle Aged , Occlusal Splints , Radiography , Retrospective Studies , Temporal Bone/diagnostic imaging , Temporomandibular Joint Disorders/therapy
11.
Clin Nephrol ; 64(3): 221-7, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16175947

ABSTRACT

We report a case of light and heavy chain deposition disease (LHCDD), a rather rare monoclonal immunoglobulin deposition disease (MIDD) with successful therapeutic effect. A 58-year-old woman suffered from proteinuria and renal insufficiency (serum creatinine 1.0 mg/dl, creatinine clearance 49.2 ml/min) in February 2003. In serum and urine samples, monoclonal IgG-kappa was detected. A bone marrow aspiration showed a slightly hypocellular marrow and plasma cell population was increased to 7.0%. Renal histological findings revealed lobulated glomeruli with nodular lesions on light microscopy, characteristic findings of MIDD. Intense deposition of IgG heavy chains in the linear pattern in the glomerular and tubular basement membranes was observed. Immunohistochemistry revealed both kappa and lambda light chain depositions in glomeruli. Electron-microscopic examination revealed fine granular electron-dense deposits accompanied by microfibrils. Based on these findings, this patient was diagnosed as LHCDD. She received three courses of melphalan and prednisone chemotherapy, resulting in disappearance of proteinuria, prevention of renal functional deterioration and the decrease of monoclonal immunoglobulin. This case clearly demonstrates that the earlier and accurate diagnosis and initiation of chemotherapy at the early stage with serum creatinine level below 4.0 mg/dl are necessary to improve renal and patient outcome.


Subject(s)
Antineoplastic Agents, Alkylating/therapeutic use , Antineoplastic Agents, Hormonal/therapeutic use , Glomerulonephritis, Membranoproliferative/drug therapy , Heavy Chain Disease/drug therapy , Immunoglobulin Heavy Chains/metabolism , Immunoglobulin Light Chains/metabolism , Drug Therapy, Combination , Female , Follow-Up Studies , Glomerulonephritis, Membranoproliferative/metabolism , Glomerulonephritis, Membranoproliferative/pathology , Heavy Chain Disease/metabolism , Heavy Chain Disease/pathology , Humans , Immunohistochemistry , Kidney Glomerulus/metabolism , Kidney Glomerulus/ultrastructure , Melphalan/therapeutic use , Microscopy, Electron , Middle Aged , Prednisolone/therapeutic use
13.
Kyobu Geka ; 58(1): 53-7, 2005 Jan.
Article in Japanese | MEDLINE | ID: mdl-15678967

ABSTRACT

We performed computed tomography (CT)-guided percutaneous radiofrequency ablation (RFA) for postoperative recurrent pulmonary metastases developed in a 77-year-old man with interstitial pneumonia. He had received left upper segmentectomy with ND 2a nodal dissection. RFA was safely performed for pulmonary metastases in right S6 and left S6. There was no evidence to suggest any deterioration on interstitial pneumonia, including KL 6 and CT findings. Autopsy revealed residual cancer cells in peripheral lesion in 1 of 2 tumors treated by RFA. Although RFA is palliative, it is a promising treatment for local control of pulmonary malignancy in high-risk patients.


Subject(s)
Carcinoma, Squamous Cell/surgery , Catheter Ablation , Lung Diseases, Interstitial/complications , Lung Neoplasms/surgery , Neoplasm Recurrence, Local/surgery , Aged , Carcinoma, Squamous Cell/diagnostic imaging , Humans , Lung Neoplasms/diagnostic imaging , Male , Neoplasm Recurrence, Local/diagnostic imaging , Tomography, X-Ray Computed
14.
Dentomaxillofac Radiol ; 33(5): 329-33, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15585811

ABSTRACT

OBJECTIVES: The purpose of this study was to analyse the relationship between temporomandibular joint (TMJ)-related pain and morphological change of the TMJ condyle in patients with temporomandibular disorders. METHODS: Data were obtained from 178 joints in 89 patients. The joints were clinically assessed for pain on mandibular function and on lateral palpation of the TMJ. They were also assessed for radiographic evidence of bone change at the articular surface (OAAS) and resorption of the lateral part of the condyle (RLC). RESULTS: A higher prevalence of joint pain on function was observed in joints with OAAS than in those without OAAS (Chi-square test of independence, P < 0.05). Significant relationships were found between palpation pain and OAAS and between palpation pain and RLC (Chi-square test of independence, P < 0.05). In addition, patients with RLC showed a significantly lower pain threshold for external mechanical stimuli than those without RLC (Welch's t-test, P < 0.05). CONCLUSIONS: These results suggest a possible relationship between pain on function and OAAS as well as a relationship between palpation pain and RLC. Pain on lateral palpation may be related to the pathological conditions that induce RLC.


Subject(s)
Facial Pain/etiology , Mandibular Condyle/pathology , Mandibular Diseases/complications , Temporomandibular Joint Disorders/complications , Adolescent , Adult , Aged , Aged, 80 and over , Bone Resorption/complications , Bone Resorption/diagnostic imaging , Child , Female , Humans , Male , Mandibular Condyle/diagnostic imaging , Mandibular Diseases/diagnostic imaging , Middle Aged , Osteoarthritis/complications , Osteoarthritis/diagnostic imaging , Osteosclerosis/complications , Osteosclerosis/diagnostic imaging , Pain Threshold/physiology , Palpation , Range of Motion, Articular/physiology , Single-Blind Method , Temporomandibular Joint Disorders/diagnostic imaging , Tomography, X-Ray
15.
Dentomaxillofac Radiol ; 32(6): 355-8, 2003 Nov.
Article in English | MEDLINE | ID: mdl-15070836

ABSTRACT

OBJECTIVE: To analyse the relationship between horizontal size and morphological changes on the articular surface and the lateral part of the mandibular condyle. METHODS: The study group comprised 139 joints in 88 women aged over 18 years. Horizontal condylar size was measured in the anteroposterior (AP) and mediolateral (ML) dimensions using axial MR images. Bony morphological change on the articular surface (sagittal change) was assessed on the sagittal MR image, and resorption of the lateral part of the condyle (RLC) was assessed on a plane radiograph in the AP projection. RESULTS: There was no significant relationship between horizontal condylar size and sagittal change. However, condyles with RLC were smaller than those without RLC in the ML dimension. CONCLUSIONS: The results of this study suggest a possible relationship between decreased horizontal condylar size and RLC. It is also suggested that sagittal bone changes do not influence the horizontal size of the condyle.


Subject(s)
Mandibular Condyle/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Bone Resorption/diagnostic imaging , Bone Resorption/pathology , Cartilage, Articular/diagnostic imaging , Cartilage, Articular/pathology , Cephalometry , Exostoses/diagnostic imaging , Exostoses/pathology , Female , Humans , Magnetic Resonance Imaging , Mandibular Condyle/diagnostic imaging , Mandibular Diseases/diagnostic imaging , Mandibular Diseases/pathology , Middle Aged , Osteoarthritis/diagnostic imaging , Osteoarthritis/pathology , Radiography , Statistics, Nonparametric , Temporomandibular Joint/diagnostic imaging , Temporomandibular Joint/pathology
16.
Int J Oncol ; 20(2): 325-31, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11788896

ABSTRACT

The objective of this study was to evaluate the clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in improving stent patency and prognosis in patients with unresectable bile duct cancer as compared with brachytherapy alone. Seventeen patients were treated. Five patients received brachytherapy alone before stent placement. Twelve patients received brachytherapy combined with external-beam radiotherapy (n=5), repeated hepatic arterial infusion chemotherapy using an implanted catheter and port (n=1), or both (n=6). Mean survival was significantly improved in the group that received combined therapy as compared with the group that received brachytherapy alone (16.2 months vs. 4.6 months, p<0.01). Although stent occlusion rates were similar in the two groups (42% vs. 40%), there was a trend towards longer stent patency in the combined therapy group than in the brachytherapy group (22 months vs. 3.6 months, p<0.2). Radiation gastritis necessitating gastrectomy developed in 1 patient who received external-beam radiotherapy at more than 50 Gy. Brachytherapy combined with external-beam radiotherapy and repeated hepatic arterial infusion chemotherapy increases survival compared with brachytherapy alone in patients with unresectable bile duct cancer.


Subject(s)
Bile Duct Neoplasms/therapy , Bile Ducts, Extrahepatic/pathology , Brachytherapy/methods , Combined Modality Therapy/methods , Aged , Aged, 80 and over , Bile Duct Neoplasms/drug therapy , Bile Duct Neoplasms/pathology , Bile Duct Neoplasms/radiotherapy , Bile Ducts, Extrahepatic/drug effects , Bile Ducts, Extrahepatic/radiation effects , Dose-Response Relationship, Radiation , Female , Humans , Male , Middle Aged , Portal Vein/surgery , Retrospective Studies , Stents , Survival Rate , Tomography, Emission-Computed
17.
Theor Appl Genet ; 105(8): 1175-1182, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12582896

ABSTRACT

To understand the genetic background of two floral anthocyanin pigmentation traits, anthocyanin pigmentation in the flower tepals and spot formation, in the Asiatic hybrid lily (2n = 24), segregation of the two traits among 96 F(1) plants derived from a cross between commercial cultivars 'Montreux' and 'Connecticut King' were investigated. 'Montreux' has anthocyanin pigmentation in the tepals with many spots, and 'Connecticut King' has flowers with carotenoid pigmentation without spots. The F(1) plants with or without anthocyanin pigment in the tepals segregated with a 1:1 segregation ratio, indicating that a single gene controls anthocyanin pigmentation in the tepals. The number of spots per square centimeter of all tepals showed continuous distribution in the F(1) plants. To map the loci for the two anthocyanin pigmentation traits, molecular linkage maps in the Asiatic hybrid lily were constructed using a double pseudo-testcross strategy, with the same F(1) plants used for phenotypic evaluation, and 212 PCR-based DNA markers. The trait for anthocyanin pigmentation in tepals was used as a trait marker. The map of 'Montreux' comprised 95 markers in 26 linkage groups, and the map of 'Connecticut King' used 119 markers in 24 linkage groups. The total map lengths were 867.5 and 1,114.8 cM, respectively. The trait locus for anthocyanin pigmentation in the tepals was between markers ASR35-180 and P506-40 in linkage group 1 of the 'Montreux' map with a map distance of 1.2 cM and 2.6 cM, respectively. A single-point analysis of quantitative trait loci (QTLs) for tepal spot number identified two putative QTLs in linkage groups 1 and 19 of the 'Connecticut King' map. One putative QTL in linkage group 19 explained 64% of the total phenotypic variation. Because both putative QTLs were mapped on the linkage map of 'Connecticut King' that has no spots, dominant alleles of them might suppress spot formation.

18.
J Vasc Interv Radiol ; 12(12): 1407-15, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11742015

ABSTRACT

PURPOSE: To identify factors affecting stent occlusion after stent placement in the portal vein in patients with malignant portal vein invasion. MATERIALS AND METHODS: Forty patients were studied. Twenty-three patients had hepatocellular carcinoma, nine patients had pancreatic cancer, and eight patients had bile duct cancer. Stents were placed in the portal venous system across stenotic (n = 28) or obstructive (n = 12) lesions after percutaneous transhepatic portography. Bare stents were used in 33 patients and covered stents were used in seven patients. Twenty-two variables were analyzed with use of univariate and multivariate analyses to identify significant factors affecting stent occlusion. RESULTS: Stents remained patent during a mean follow-up period of 11.9 months (range, 2-61 mo) in 60% of the patients. Stent occlusion was found in 40% of the patients, with a mean period until occlusion of 3.7 months (range, 0.2-16 mo). In the univariate analysis, the following five factors were significantly associated with a higher probability of stent occlusion: (i) splanchnic vein involvement, (ii) Child-Pugh class C, (iii) obstruction of the portal venous system, (iv) pancreatic cancer, and (v) lack of anticancer treatment after stent placement. In the multivariate analysis, the first three factors were found to have independent value for stent occlusion. CONCLUSIONS: Splanchnic vein involvement, severe hepatic dysfunction, and obstruction of the portal venous system are the most important factors affecting stent occlusion in patients with malignant portal vein invasion.


Subject(s)
Bile Duct Neoplasms/pathology , Carcinoma, Hepatocellular/pathology , Liver Neoplasms/pathology , Neoplastic Cells, Circulating/pathology , Pancreatic Neoplasms/pathology , Portal Vein/pathology , Stents , Adult , Aged , Female , Humans , Male , Middle Aged , Multivariate Analysis , Neoplasm Invasiveness , Portography , Vascular Patency
19.
Gan To Kagaku Ryoho ; 28(11): 1498-500, 2001 Oct.
Article in Japanese | MEDLINE | ID: mdl-11707963

ABSTRACT

This study was performed to evaluate the feasibility and clinical impact of intraluminal and endovascular high-dose-rate iridium-192 brachytherapy on the treatment of HCC lesions growing into biliary trees, portal veins and the inferior vena cava. HCCs involving biliary trees in 2 patients, the main and/or first-order portal veins in 3 patients, and the inferior vena cava in 2 patients. Brachytherapy was percutaneously performed with a 5F applicator, which was placed adjacent to the lesions. A mean total dose of 23 Gy (range, 5-7 Gy/fr) was irradiated (at a 5 mm radius) to the biliary or the portal venous tumors. A total dose of 10 Gy (5 Gy/fr) was given to the caval tumors. External-beam radiotherapy was combined in 2 patients with caval lesions, stent placement in 2 patients with biliary lesions and hepatic arterial infusion chemotherapy in 5 patients. There was no major complication except hemobilia, which ceased after placing a PTCD tube in the bile duct in one patient. All tumors were significantly reduced in size and remained controlled during the period of patients' survival. Complete tumor necrosis was histologically proved in 2 autopsy cases having biliary lesions. The median survival was 13 months. Intraluminal and endovascular high-dose-rate brachytherapy appears to be a feasible, and effective procedure to treat advanced HCCs invading biliary trees, portal veins and the vena cava.


Subject(s)
Brachytherapy , Carcinoma, Hepatocellular/radiotherapy , Liver Neoplasms/radiotherapy , Vascular Neoplasms/radiotherapy , Aged , Biliary Tract/pathology , Brachytherapy/standards , Carcinoma, Hepatocellular/pathology , Feasibility Studies , Female , Humans , Iridium Radioisotopes/administration & dosage , Liver Neoplasms/pathology , Male , Middle Aged , Neoplasm Invasiveness , Portal Vein/pathology , Radiotherapy Dosage , Vascular Neoplasms/pathology , Venae Cavae/pathology
20.
Gan To Kagaku Ryoho ; 28(11): 1493-6, 2001 Oct.
Article in Japanese | MEDLINE | ID: mdl-11707962

ABSTRACT

This study was undertaken to evaluate the clinical utility of chemoembolization using degradable starch microspheres (DSM), which resolve in a short period in patients with advanced hepatocellular carcinoma (HCC). Twenty-one patients underwent DSM chemoembolization 24 times. After a mixture of iodized oil and epirubicin was injected into the hepatic arteries, the patients were embolized with DSM alone 16 times. In the other 8 times, embolization was done in one hepatic lobe with DSM and in the other hepatic lobe with gelatin sponge (GS). There was no major complication related to chemoembolization. Tumor response (complete, partial, and minor responses) was found in 46% of patients after TAE. Tumor recurrence was found in 64% of responders after a mean period of 2.0 months. The response rate was significantly higher when chemoembolization was performed using both DSM and GS than when it was done with DSM alone (63% vs 37%, p < 0.04). Although the response rate after DSM-TAE is low, its anticancer effect is reinforced when used as an adjuvant therapy of GS-TAE.


Subject(s)
Carcinoma, Hepatocellular/therapy , Chemoembolization, Therapeutic , Liver Neoplasms/therapy , Starch/administration & dosage , Aged , Antibiotics, Antineoplastic/administration & dosage , Epirubicin/administration & dosage , Female , Gelatin Sponge, Absorbable/administration & dosage , Humans , Iodized Oil/administration & dosage , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...